Virginia Rep. Jennifer Wexton to Retire After “Parkinson’s on Steroids” Diagnosis

VIRGINIA – Democratic Representative Jennifer Wexton of Virginia has announced that she will not seek reelection next year due to a new and severe medical diagnosis she received from her doctors, describing it as “Parkinson’s on steroids.” In a statement posted on X (formerly Twitter), Wexton opened up about her diagnosis and expressed her commitment to honesty in public service.

Wexton, serving her third term in Congress, initially revealed her Parkinson’s diagnosis, a nervous system disorder known to affect movement and cause tremors, in April. However, as her treatment showed no signs of progress and her symptoms diverged from those of individuals in her Parkinson’s support group, she sought further medical evaluation and expert opinions.

The revised diagnosis for Wexton is progressive supra-nuclear palsy, a rare and incurable brain disorder.

After inquiring with her doctor about the possibility of running for reelection next autumn, her doctor reportedly responded, “Why would you want to?” as reported by The Washington Post.

In her statement on Monday, Wexton expressed her intention to complete her current term in office and then dedicate her remaining years to her husband, two sons, and loved ones. She expressed deep sorrow at having to relinquish something she had cherished for many years while serving her community.

Representing a district in northern Virginia that had long been a Republican stronghold, Wexton achieved her election victory in 2018, unseating GOP incumbent Barbara Comstock.

Senator Tim Kaine of Virginia shared a photo of Wexton dressed as Wonder Woman on Halloween in 2018, reminiscing about her remarkable dedication to public service, listening to her constituents, and advocating for their needs. He expressed his sadness at her departure from Congress and conveyed his thoughts and prayers for her.

Wexton’s retirement has sparked discussions about the upcoming congressional race in her district, which is likely to be hotly contested in the 2024 elections.